Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.20.2
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Concentration Risk [Line Items]        
Revenues $ 74,329 $ 91,761 $ 234,509 $ 283,026
U.S. revenue        
Concentration Risk [Line Items]        
Revenues 59,748 73,269 185,971 222,167
Non-U.S. revenue        
Concentration Risk [Line Items]        
Revenues $ 14,581 $ 18,492 $ 48,538 $ 60,859